Back to dashboard
Episode 39
DIP Episode 39 - Neuro Pharmacology Part 2 (Seizure Meds)
PharmacologyMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Seizures (Febrile, West Syndrome); Anti-epileptic drugs (Phenytoin, Carbamazepine, Phenobarbital, Lamotrigine)...
Key Takeaway
The management of acute seizures follows a stepwise approach: Benzodiazepines -> Phenytoin/Fosphenytoin -> Barbiturates; furthermore, anti-epileptic drugs can induce or inhibit CYP450 enzymes and are implicated in metabolic disorders like porphyria.
Runtime: 30.2 min
Published: 2018-07-05
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: NEURO, PHARMACOLOGY
Episode Notes
Source / episode info
- Episode: 39
- Title: Divine Intervention Episode 39 – Neuro Pharmacology Part 2 (Seizure Meds).
- Published: 2018-07-05
- Source: Episode page
One-liner
This episode covers the clinical presentation of various seizures (Febrile, West Syndrome), details the mechanisms and side effects of key anti-epileptic drugs (Phenytoin, Carbamazepine, Phenobarbital, Lamotrigine), and integrates these concepts with metabolic disorders like Acute Intermittent Porphyria.
High-yield summary
- Atypical Febrile Seizures: Any finding suggesting a non-febrile cause—such as focal seizures, multiple seizures in 24 hours, or associated neurological deficits—requires full workup (e.g., EEG, CT).
- West Syndrome: This triad of intellectual disability, infantile spasms, and hypsarrhythmia on EEG is classically associated with underlying causes like tuberous sclerosis complex (TSC) and can be treated with ACTH (first line).
- Anti-seizure Drug Metabolism: Phenytoin, Carbamazepine, and Phenobarbital are potent inducers of Cytochrome P450 enzymes (GNCBPRS), requiring dose adjustments for co-administered drugs.
- Porphyrias: Acute Intermittent Porphyria (AIP) is characterized by the buildup of porphyrin precursors due to deficiency of Porphobilinogen deaminase; this condition can be precipitated by barbiturates and treated with glucose.
- GAB Aergic Drugs: Phenobarbital, benzodiazepines, and barbiturates are GABA-A receptor agonists causing hyperpolarization; their withdrawal is often fatal, and benzos can be reversed by Flumazenil.
Learning objectives
- Differentiate between typical and atypical febrile seizures, recognizing when a full neurological workup is required.
- Identify the classic triad and first-line treatment for West Syndrome (Infantile Spasms).
- Understand the mechanism of action and clinical implications of major anti-seizure drugs (e.g., sodium channel blockade, GABA agonism, CYP induction).
- Recognize the metabolic consequences of certain anti-epileptics (e.g., Phenytoin causing folate deficiency; Barbiturates precipitating porphyria).
- Apply knowledge of drug reversal agents for overdose scenarios involving CNS depressants.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| West Syndrome | Infantile spasms, Intellectual disability, Hypsarrhythmia (EEG) | Tuberous Sclerosis Complex (TSC); ACTH treatment | Always remember the triad and that ACTH is the first-line drug. |
| Phenytoin/Carbamazepine | CYP Induction | GNCBPRS (Phenytoin, Carbamazepine, Phenobarbital, Rifampin, St. John's Wort) | These drugs increase metabolism; anticipate needing higher doses of co-administered medications. |
| Acute Intermittent Porphyria (AIP) | Nausea/Vomiting, Abdominal pain, Neuropathy | Precipitated by barbiturates; Deficiency in Porphobilinogen deaminase | Treat with glucose or porphyrin precursors to inhibit the pathway flux. |
| Benzodiazepine Overdose | Respiratory depression | GABA-A receptor agonism | Reversal agent is Flumazenil. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Febrile Seizures | Atypical findings (focal, >1 seizure/24h) require workup. | Fever in children < 5 years old. | Distinguishing simple febrile seizures from underlying CNS pathology is critical. |
| Phenytoin Metabolism | Zero-order elimination; potent CYP inducer. | Chronic use of multiple drugs. | Requires dose adjustments for co-administered medications (e.g., oral contraceptives). |
| West Syndrome Treatment | ACTH is first line, followed by steroids or Vigabatrin. | Severe epilepsy syndrome in infancy. | High-yield association that often appears on board exams despite seeming counterintuitive. |
| Porphyria Management | Inducing the pathway (e.g., with barbiturates) causes crisis. | Deficiency of PBGD; buildup of porphyrin precursors. | Knowing which drugs precipitate porphyria is key for patient safety. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A child presents with a high fever and generalized seizure, but the EEG shows focal activity and multiple seizures over 24 hours. | Atypical Febrile Seizure Workup | The presence of atypical features (focal/multiple) mandates ruling out underlying causes beyond simple febrile illness. |
| A young male patient is diagnosed with intellectual disability, infantile spasms, and a chaotic hypsarrhythmia pattern on EEG. | West Syndrome | This classic triad defines the syndrome; ACTH is the first-line treatment for this severe epilepsy. |
| A patient taking Phenytoin develops signs of megaloblastic anemia and elevated homocysteine levels. | Folate/B12 Deficiency (Folate trapping) | Phenytoin inhibits folate absorption by interfering with the enzyme conjugase, leading to functional deficiency, which elevates homocysteine. |
| A child presents with recurrent unilateral shooting pain in the distribution of CN V, refractory to standard care. | Trigeminal Neuralgia | The first-line pharmacological treatment is Carbamazepine; it blocks sodium channels and is used for this specific condition. |
| A patient develops a rash, abdominal pain, and neurological deficits after starting Phenytoin. | Acute Intermittent Porphyria (AIP) | Barbiturates/Phenytoin induce the heme synthesis pathway, leading to toxic buildup of porphyrin precursors (like PBG), which are neurotoxic. |
| A patient is given a benzodiazepine for status epilepticus and subsequently requires reversal due to respiratory depression. | Benzodiazepine Overdose Reversal | Flumazenil is the specific competitive antagonist that reverses the effects of benzodiazepines on the GABA-A receptor complex. |
Differential diagnosis / distinguishing features
Anti-seizure Drug Side Effects
| Key Features | Distinguishing Findings | Next Step |
| Phenytoin/Carbamazepine | Gingivol hyperplasia, SJS, CYP induction. | Monitor blood levels and adjust doses of narrow therapeutic index drugs (e.g., warfarin). |
| Phenytoin | Megaloblastic anemia; elevated homocysteine. | Supplementation with Folic Acid is required due to inhibition of folate absorption. |
| Carbamazepine | SIADH risk, CYP induction. | Monitor serum sodium and urine osmolality if SIADH is suspected. |
GAB Aergic Drugs (Phenobarbital vs Benzodiazepines)
| Key Features | Distinguishing Findings | Next Step |
| Phenobarbital/Benzos/Barbs | All are GABA-A agonists; cause respiratory depression. | Flumazenil reverses benzodiazepine overdose specifically. Barbiturates have no specific reversal agent. |
| Clonazepam (or other Z-drugs) | Used for insomnia; also GAB Aergic. | These drugs can be reversed by Flumazenil, making them a classic test question pairing. |
Management pearls
- Acute Status Epilepticus: Start with Benzodiazepines (Diazepam/Lorazepam). If refractory, proceed to Phenytoin/Fosphenytoin. If still failing, administer Barbiturates (e.g., Phenobarbital).
- Phenytoin Dosing: Due to its zero-order elimination kinetics, phenytoin can accumulate rapidly in the bloodstream, necessitating careful monitoring of infusion rates and plasma levels.
- Porphyria Crisis Management: The primary treatment is administering Glucose or porphyrin precursors (like PBG) to inhibit the rate-limiting enzyme (ALA synthase) and prevent further buildup of toxic intermediates.
- Wilson's Disease: Treatment involves chelation therapy (e.g., D-penicillamine, Trientine).
Don't miss
🚨
West Syndrome Diagnosis: Must recognize the triad: Intellectual disability, Infantile spasms, Hypsarrhythmia on EEG.
🚨
Phenytoin/Carbamazepine Side Effects: Remember the mnemonic GNCBPRS for CYP induction (Gingivol hyperplasia, Nausea, Confusion, Barbiturates, Phenytoin, Rifampin, St. John's Wort).
🚨
Porphyria Trigger: Barbiturates are potent inducers of the heme synthesis pathway and should be avoided in patients with porphyrias.
🚨
Folate Deficiency: Phenytoin interferes with folate absorption by inhibiting conjugase, leading to high homocysteine but normal methylmalonic acid levels (unlike B12 deficiency).
Integration & clinical reasoning
- Pharmacogenetics/Drug Metabolism: The induction of CYP enzymes by multiple anti-seizure drugs (Phenytoin, Carbamazepine) is a critical concept for predicting drug interactions and adjusting dosing in complex patients.
- Metabolic Toxicology: Porphyrias demonstrate how enzyme deficiencies can lead to the accumulation of toxic intermediates that affect multiple organ systems (skin, neuro).
- GAB Aergic Pharmacology: The differential action on GABA-A vs GABA-B receptors is key; benzodiazepines are agonists at GABA-A, while Baclofen is an agonist at GABA-B.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Acute Status Epilepticus: Standard emergency management takes priority over OMT. The initial focus is rapid stabilization and administration of Benzodiazepines (Lorazepam/Diazepam). Phenytoin/Fosphenytoin are standard second-line agents, followed by barbiturates if refractory.
- Metabolic Crisis (Porphyria): In a suspected porphyric crisis, the priority is avoiding precipitating drugs (like barbiturates) and managing symptoms with glucose or porphyrin precursors. OMT should not be used to induce metabolic flux in this setting.
Concept connections / cross-references
- For detailed information on the metabolic pathways and deficiencies of B12/Folate, review concepts covered in [Episode 37].
- The concept of enzyme induction (CYP450) is related to drug interactions discussed generally in [Episode 38].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| West Syndrome | ACTH treatment | Unknown; likely involves adrenal cortical stimulation. | First-line therapy for infantile spasms, a high-yield association on board exams. |
| Phenytoin/Carbamazepine | CYP Induction | Inhibition of metabolic enzymes (CYP450). | Requires increased dosing of co-administered drugs like oral contraceptives or warfarin. |
| Acute Intermittent Porphyria (AIP) | Barbiturates, Aminoguanidine | Induce the heme synthesis pathway; buildup of porphyrin precursors. | Leads to acute neurotoxicity and is a major contraindication for these agents. |
| Phenytoin | Folate Deficiency | Inhibition of conjugase enzyme required for folate absorption. | Causes megaloblastic anemia and elevated homocysteine, but not methylmalonic acid. |
Key terms glossary
| Term | Definition | Context | Example |
| Hypsarrhythmia | A chaotic, high-amplitude pattern on EEG. | West Syndrome/Infantile Spasms. | Used to diagnose the severe epileptic encephalopathy associated with this syndrome. |
| GABA-A Receptor Agonist | Drugs that enhance GABA's inhibitory effect by increasing chloride influx. | Anti-seizure medications (Benzos, Phenobarbital). | Benzodiazepines are classic examples; they cause hyperpolarization and neuronal inhibition. |
| CYP Induction | Increased activity of Cytochrome P450 enzymes. | Effect of drugs like Phenytoin or Carbamazepine. | Leads to faster metabolism of co-administered drugs (e.g., oral contraceptives). |
| Acute Intermittent Porphyria (AIP) | A metabolic disorder causing buildup of porphyrin precursors. | Deficiency in Porphobilinogen deaminase. | Precipitated by barbiturates; treated with glucose/PBG to inhibit the pathway. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Seizure Workup | Master the differential diagnosis (Febrile vs Atypical) and the acute management algorithm. | High | Review clinical vignettes; practice stepwise drug administration. |
| Drug Mechanisms/Toxicity | Focus on why drugs cause side effects (e.g., Phenytoin -> Folate trapping; Barbiturates -> Porphyria induction). | Highest | Create flowcharts for drug metabolism and toxicity pathways. |
| Metabolic Disorders | Memorize the specific enzyme deficiency, the toxic metabolite, and the antidote/treatment (e.g., AIP -> PBGD deficiency -> Glucose treatment). | High | Use mnemonics to link drugs to metabolic consequences. |
Question pattern recognition
- Step 1 Pattern: Recognizing drug side effects related to metabolic pathways (e.g., Phenytoin causing folate trapping; Carbamazepine causing SIADH).
- Step 2 Pattern: Applying the correct acute management algorithm for status epilepticus (Benzos -> Phenytoin -> Barbiturate).
- Step 3 Pattern: Differentiating between similar-sounding syndromes or drugs based on specific clinical findings (e.g., distinguishing opioid vs benzo intoxication pupillary changes).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing Febrile vs Atypical Seizures. Assuming that because the fever was low grade, the seizure must be simple febrile. Correction: Always investigate atypical features (focal/multiple seizures) regardless of fever severity.
🚫
Mistake 2: Misunderstanding CYP Induction. Thinking that all anti-seizure drugs induce CYP enzymes equally or in the same manner. Correction: Remember the mnemonic GNCBPRS and understand that induction increases metabolism, requiring dose escalation for co-meds.
🚫
Mistake 3: Incorrect Porphyria Management. Administering barbiturates to a patient with suspected porphyria. Correction: Barbiturates are potent inducers of the pathway; use glucose or porphyrin precursors instead.
Common traps
⚠️
Trap 1 (Phenytoin/Folate): The trap is confusing Phenytoin's effect on folate absorption (inhibiting conjugase) with B12 deficiency, which causes both elevated homocysteine and elevated methylmalonic acid.
⚠️
Trap 2 (Seizure Management): Assuming the management algorithm is linear without considering drug availability or patient status. The sequence must be Benzodiazepine -> Phenytoin/Fosphenytoin -> Barbiturate.
⚠️
Trap 3 (GABA Reversal): Mistaking the reversal agent for benzodiazepines. While many drugs depress CNS function, only Flumazenil specifically reverses benzos on the GABA-A receptor.